Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs

Cancer Research

Volumn 56, Issue 19, 1996, Pages 4366-4369

  Fan, Huizhou ^a   Villegas, Cristy ^a   Huang, Aiping ^a   Wright, Jim A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; MESSENGER RNA; RIBONUCLEOTIDE REDUCTASE;

ARTICLE; CANCER INHIBITION; CARCINOGENESIS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GROWTH REGULATION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; METASTASIS; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; FIBROBLASTS; GENE THERAPY; GENES, MYC; GENES, P53; GENES, RAS; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; PLASMIDS; REGULATORY SEQUENCES, NUCLEIC ACID; RIBONUCLEOTIDE REDUCTASES; RNA; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029776812     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wright, J. A., Chan, A K., Choy, B. K., Hurta, R A. R., McClarty, G A., and Tagger, A Y. Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase and the significance to DNA synthesis Biochem. Cell Biol., 68: 1364-1371, 1990.
2. Wright, J. A Altered mammalian ribonucleotide reductase from mutant cell lines. Encycl. Pharmacol. Therapeut., 128: 89-111, 1989.
3. Wright, J. A., McClarty, G. A., Lewis, W H., and Srinivasan, P. R. Hydroxyurea and related compounds. In: R. S. Gupta (ed.), Drug Resistance in Mammalian Cells, pp. 15-27 Boca Raton, FL: CRC Press, Inc , 1989.
4. Hurta, R. A. R , and Wright, J. A. Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent J. Biol. Chem , 267: 7066-7071, 1992.
5. Stubbe, J A. Protein radical involvement in biological catalysis? Annu Rev. Biochem , 58: 257-285, 1989
6. Weber, G Biochemical strategy of cancer cells and the design of chemotherapy. Cancer Res , 43: 3466-3492, 1983.
7. Amara, R. M., Chen, F. Y., and Wright, J. A. Phorbol ester modulation of a novel cytoplasmic protein binding activity at the 3′-untranslated region of mammalian ribonucleotide reductase R2 mRNA and role in message stability J. Biol Chem , 269: 6709-7071, 1994.
8. Chen, F. Y , Amara, F M , and Wright, J A Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbol ester stimulating conditions: involvement of a cis-trans interaction at the 3′ untranslated region EMBO J , 12: 3977-3986, 1993
9. Chen, F. Y., Amara, F M , and Wright, J. A Regulation of mammalian ribonucleotide reductase R1 mRNA stability is mediated by a ribonucleotide reductase R1 mRNA 3′-untranslated region cis-trans interaction through a protein kinase C-controlled pathway Biochem. J., 302, 125-132, 1994.
10. Chen, F. Y , Amara, F. M., and Wright, J. A. Defining a novel ribonucleotide reductase R1 mRNA cis element that binds to an unique cytoplasmic trans-acting protein. Nucleic Acids Res , 22: 4796-4797, 1994.
11. Amara, F. M , Hurta, R A. R., Huang, A., and Wright, J. A. Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNAs in hydroxyurea-resistant cells Cancer Res , 55, 4503-4506, 1995
12. 1 induced mRNA stabilization. Nucleic Acids Res , 23: 1461-1467, 1995.
13. 1. J. Cell. Biochem., 57 543-556, 1995
14. Kimelman, D., and Kirschner, M. W. An antisense mRNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes. Cell, 59: 687-696, 1989.
15. Lee, R C., Feinbaum, R. L., and Ambros, V. The C. elegans heterochromic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-854, 1993.
16. Farrell, C. M , and Lukens, L. N. Naturally occurring antisense transcripts are present in chick embryo chondrocytes simultaneously with the down-regulation of the α1 (I) collagen gene J. Biol. Chem , 270: 3400-3408, 1995.
17. Rastinejad, F., Conboy, M J., Rando, T. A., and Blau, H. M. Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin Cell, 75: 1107-1117, 1993.
18. Thelander, L., and Berg, P. Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase Mol Cell. Biol . 6: 3433-3442, 1986.
19. Fan, H., McClarty, G., and Brunham, R. C Cloning of a gene from Chlamydia trachomatis that complements thymidylate synthase-deficient Escherichia coli. Abstracts of the 94th General Meeting of the American Society for Microbiology, p. 134, 1994.
20. Taylor, W R., Egan, S E., Mowat, M., Greenberg, A H , and Wright, J A Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination Oncogene, 7: 1383-1390, 1992
21. Huang, A , Jin, H., Taylor, W R., and Wright, J. A. Multiple effects on drug sensitivity, genome stability and malignant potential by combinations of H-ras, c-myc and mutant p53 gene overexpression. Int J. Oncol, 7: 57-63, 1995.
22. Huang, A , and Wright, J. A. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification Oncogene, 9: 491-499, 1994
23. Egan, S. E., Wright, J. A., Jarolim, L , Yanagihara, K., Bassin, R H., and Greenberg, A H, Transformation by oncogenes encoding protein kinases induces the metastatic phenotype Science (Washington DC), 238: 202-205, 1987.
24. Damen, J E., Tagger, A Y., Greenberg, A. H., and Wright, J. A. Generation of metastatic variants in populations of mutator and amplificator mutants. J. Natl Cancer Inst., 81 628-631, 1989.
25. Nowell, P C. Mechanisms of tumor progression. Cancer Res., 46: 2203-2207, 1986
26. Wright, J. A , Turley, E A , and Greenberg, A H Transforming growth factor β and fibroblast growth factor as promoters of tumor progression to malignancy. Crit. Rev. Oncog., 4: 473-492, 1993.
27. 1 inhibition to stimulation in metastatic H-ras-transformed marine fibroblasts Cancer Res , 48: 6999-7003, 1988.
28. 1 gene expression and alterations in the growth and malignant properties of mouse fibrosarcoma cells. Gene (Amst.), 149: 25-29, 1994.
29. 1 in malignant H-ras transformed cell lines. J Biol. Chem., 266: 24097-24100, 1991